Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $33.15 | Total: $165.75 |
| 1 | 10 | $28.08 | Total: $280.80 |
| 1 | 25 | $23.79 | Total: $594.75 |
| 1 | 50 | $20.28 | Total: $1,014.00 |
| 1 | 100 | $17.55 | Total: $1,755.00 |
Overview
TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.
Chemical Properties
| Molecular Formula | C16H19N3O2S |
| Molecular Weight | 317.41 |
| CAS Numbers | 494772-87-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C(N)C=1SC(=CC1N)C=2C=CC(=CC2)CN3CCOCC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
AstraZeneca A.B,et al. Preparation of ureido-carboxamido thiophenes as inhibitors of IKK2 kinase. WO2003010158 A1.